| UniProt ID | NUSAP_HUMAN | |
|---|---|---|
| UniProt AC | Q9BXS6 | |
| Protein Name | Nucleolar and spindle-associated protein 1 | |
| Gene Name | NUSAP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 441 | |
| Subcellular Localization | Cytoplasm. Nucleus, nucleolus. Cytoplasm, cytoskeleton, spindle. Chromosome. Found in the cytoplasm and nucleolus during interphase and redistributes to the mitotic spindle in prometaphase (By similarity). Localizes to the mitotic spindle during anap | |
| Protein Description | Microtubule-associated protein with the capacity to bundle and stabilize microtubules (By similarity). May associate with chromosomes and promote the organization of mitotic spindle microtubules around them.. | |
| Protein Sequence | MIIPSLEELDSLKYSDLQNLAKSLGLRANLRATKLLKALKGYIKHEARKGNENQDESQTSASSCDETEIQISNQEEAERQPLGHVTKTRRRCKTVRVDPDSQQNHSEIKISNPTEFQNHEKQESQDLRATAKVPSPPDEHQEAENAVSSGNRDSKVPSEGKKSLYTDESSKPGKNKRTAITTPNFKKLHEAHFKEMESIDQYIERKKKHFEEHNSMNELKQQPINKGGVRTPVPPRGRLSVASTPISQRRSQGRSCGPASQSTLGLKGSLKRSAISAAKTGVRFSAATKDNEHKRSLTKTPARKSAHVTVSGGTPKGEAVLGTHKLKTITGNSAAVITPFKLTTEATQTPVSNKKPVFDLKASLSRPLNYEPHKGKLKPWGQSKENNYLNQHVNRINFYKKTYKQPHLQTKEEQRKKREQERKEKKAKVLGMRRGLILAED | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 5 | Phosphorylation | ---MIIPSLEELDSL ---CCCCCHHHHHHC | 37.70 | 26552605 | |
| 11 | Phosphorylation | PSLEELDSLKYSDLQ CCHHHHHHCCHHHHH | 39.11 | 26552605 | |
| 33 | Phosphorylation | LRANLRATKLLKALK HHHHHHHHHHHHHHH | 18.78 | - | |
| 57 | Phosphorylation | GNENQDESQTSASSC CCCCCCHHHCCHHHC | 47.23 | 23663014 | |
| 59 | Phosphorylation | ENQDESQTSASSCDE CCCCHHHCCHHHCCC | 35.22 | 23663014 | |
| 60 | Phosphorylation | NQDESQTSASSCDET CCCHHHCCHHHCCCC | 20.65 | 23663014 | |
| 62 | Phosphorylation | DESQTSASSCDETEI CHHHCCHHHCCCCEE | 31.13 | 23663014 | |
| 63 | Phosphorylation | ESQTSASSCDETEIQ HHHCCHHHCCCCEEE | 25.88 | 23663014 | |
| 67 | Phosphorylation | SASSCDETEIQISNQ CHHHCCCCEEECCCH | 25.74 | 23663014 | |
| 84 | Ubiquitination | AERQPLGHVTKTRRR HHHCCCCCHHHCCCC | 31.58 | 24816145 | |
| 87 | Acetylation | QPLGHVTKTRRRCKT CCCCCHHHCCCCEEE | 38.66 | 25953088 | |
| 99 | Ubiquitination | CKTVRVDPDSQQNHS EEEEEECCCCCCCCC | 40.05 | 24816145 | |
| 101 | Phosphorylation | TVRVDPDSQQNHSEI EEEECCCCCCCCCCC | 38.77 | 25849741 | |
| 106 | Phosphorylation | PDSQQNHSEIKISNP CCCCCCCCCCCCCCC | 48.87 | 25159151 | |
| 109 (in isoform 4) | Phosphorylation | - | 35.71 | 25849741 | |
| 109 (in isoform 6) | Phosphorylation | - | 35.71 | 25849741 | |
| 111 | Phosphorylation | NHSEIKISNPTEFQN CCCCCCCCCCHHHCC | 31.58 | 23186163 | |
| 114 | Phosphorylation | EIKISNPTEFQNHEK CCCCCCCHHHCCCCH | 54.40 | 23186163 | |
| 121 | Ubiquitination | TEFQNHEKQESQDLR HHHCCCCHHHCCCHH | 52.38 | 16196087 | |
| 124 | Phosphorylation | QNHEKQESQDLRATA CCCCHHHCCCHHHHC | 26.88 | 17525332 | |
| 130 | Phosphorylation | ESQDLRATAKVPSPP HCCCHHHHCCCCCCC | 22.15 | 24732914 | |
| 132 | Acetylation | QDLRATAKVPSPPDE CCHHHHCCCCCCCHH | 50.77 | 25953088 | |
| 135 | Phosphorylation | RATAKVPSPPDEHQE HHHCCCCCCCHHHHH | 52.64 | 29255136 | |
| 139 | Ubiquitination | KVPSPPDEHQEAENA CCCCCCHHHHHHHHH | 53.93 | 24816145 | |
| 147 | Ubiquitination | HQEAENAVSSGNRDS HHHHHHHHHCCCCCC | 7.64 | 24816145 | |
| 148 | Phosphorylation | QEAENAVSSGNRDSK HHHHHHHHCCCCCCC | 30.07 | 25159151 | |
| 148 | Ubiquitination | QEAENAVSSGNRDSK HHHHHHHHCCCCCCC | 30.07 | 16196087 | |
| 149 | Phosphorylation | EAENAVSSGNRDSKV HHHHHHHCCCCCCCC | 33.22 | 25159151 | |
| 151 | Ubiquitination | ENAVSSGNRDSKVPS HHHHHCCCCCCCCCC | 46.67 | 16196087 | |
| 153 | Ubiquitination | AVSSGNRDSKVPSEG HHHCCCCCCCCCCCC | 57.73 | 24816145 | |
| 154 | Phosphorylation | VSSGNRDSKVPSEGK HHCCCCCCCCCCCCC | 32.11 | 25056879 | |
| 156 | Ubiquitination | SGNRDSKVPSEGKKS CCCCCCCCCCCCCCC | 7.94 | 16196087 | |
| 158 | Phosphorylation | NRDSKVPSEGKKSLY CCCCCCCCCCCCCCC | 63.07 | 26055452 | |
| 159 | Ubiquitination | RDSKVPSEGKKSLYT CCCCCCCCCCCCCCC | 69.80 | 16196087 | |
| 161 | Ubiquitination | SKVPSEGKKSLYTDE CCCCCCCCCCCCCCC | 34.83 | 24816145 | |
| 162 | Ubiquitination | KVPSEGKKSLYTDES CCCCCCCCCCCCCCC | 57.46 | 24816145 | |
| 164 | Ubiquitination | PSEGKKSLYTDESSK CCCCCCCCCCCCCCC | 7.98 | 29967540 | |
| 165 | Phosphorylation | SEGKKSLYTDESSKP CCCCCCCCCCCCCCC | 21.16 | 25884760 | |
| 165 | Ubiquitination | SEGKKSLYTDESSKP CCCCCCCCCCCCCCC | 21.16 | 16196087 | |
| 166 | Phosphorylation | EGKKSLYTDESSKPG CCCCCCCCCCCCCCC | 38.29 | 28555341 | |
| 167 | Ubiquitination | GKKSLYTDESSKPGK CCCCCCCCCCCCCCC | 39.98 | 24816145 | |
| 168 | Ubiquitination | KKSLYTDESSKPGKN CCCCCCCCCCCCCCC | 49.46 | 24816145 | |
| 169 | Phosphorylation | KSLYTDESSKPGKNK CCCCCCCCCCCCCCC | 46.61 | 28985074 | |
| 170 | Phosphorylation | SLYTDESSKPGKNKR CCCCCCCCCCCCCCC | 40.60 | - | |
| 170 | Ubiquitination | SLYTDESSKPGKNKR CCCCCCCCCCCCCCC | 40.60 | 16196087 | |
| 171 | Ubiquitination | LYTDESSKPGKNKRT CCCCCCCCCCCCCCC | 68.05 | 16196087 | |
| 172 | Ubiquitination | YTDESSKPGKNKRTA CCCCCCCCCCCCCCE | 62.02 | 29967540 | |
| 173 | Ubiquitination | TDESSKPGKNKRTAI CCCCCCCCCCCCCEE | 50.32 | 16196087 | |
| 174 | Ubiquitination | DESSKPGKNKRTAIT CCCCCCCCCCCCEEE | 68.75 | 16196087 | |
| 176 | Ubiquitination | SSKPGKNKRTAITTP CCCCCCCCCCEEECC | 55.39 | 16196087 | |
| 177 | Ubiquitination | SKPGKNKRTAITTPN CCCCCCCCCEEECCC | 38.49 | 16196087 | |
| 178 | Phosphorylation | KPGKNKRTAITTPNF CCCCCCCCEEECCCH | 24.83 | 30266825 | |
| 179 | Ubiquitination | PGKNKRTAITTPNFK CCCCCCCEEECCCHH | 10.93 | 16196087 | |
| 180 | Ubiquitination | GKNKRTAITTPNFKK CCCCCCEEECCCHHH | 4.33 | 16196087 | |
| 181 | Phosphorylation | KNKRTAITTPNFKKL CCCCCEEECCCHHHH | 33.46 | 30266825 | |
| 182 | Phosphorylation | NKRTAITTPNFKKLH CCCCEEECCCHHHHH | 15.32 | 30266825 | |
| 186 | Acetylation | AITTPNFKKLHEAHF EEECCCHHHHHHHHH | 62.15 | 25953088 | |
| 186 | Methylation | AITTPNFKKLHEAHF EEECCCHHHHHHHHH | 62.15 | 115974413 | |
| 186 | Ubiquitination | AITTPNFKKLHEAHF EEECCCHHHHHHHHH | 62.15 | 29967540 | |
| 187 | Ubiquitination | ITTPNFKKLHEAHFK EECCCHHHHHHHHHH | 51.44 | 29967540 | |
| 192 (in isoform 7) | Phosphorylation | - | 31.18 | 20068231 | |
| 198 | Phosphorylation | AHFKEMESIDQYIER HHHHHHHHHHHHHHH | 30.10 | 28674419 | |
| 200 (in isoform 4) | Phosphorylation | - | 44.50 | 20068231 | |
| 214 (in isoform 3) | Phosphorylation | - | 46.35 | 20068231 | |
| 215 | Phosphorylation | KHFEEHNSMNELKQQ HHHHHHCCHHHHHCC | 25.54 | 20068231 | |
| 215 (in isoform 2) | Phosphorylation | - | 25.54 | 20068231 | |
| 231 | Phosphorylation | INKGGVRTPVPPRGR CCCCCCCCCCCCCCC | 26.65 | 30266825 | |
| 233 | Ubiquitination | KGGVRTPVPPRGRLS CCCCCCCCCCCCCCE | 11.44 | 24816145 | |
| 240 | Phosphorylation | VPPRGRLSVASTPIS CCCCCCCEEECCCHH | 17.80 | 30266825 | |
| 243 | O-linked_Glycosylation | RGRLSVASTPISQRR CCCCEEECCCHHHCH | 32.34 | 31373491 | |
| 243 | Phosphorylation | RGRLSVASTPISQRR CCCCEEECCCHHHCH | 32.34 | 30266825 | |
| 243 | Ubiquitination | RGRLSVASTPISQRR CCCCEEECCCHHHCH | 32.34 | 33845483 | |
| 244 | Phosphorylation | GRLSVASTPISQRRS CCCEEECCCHHHCHH | 18.20 | 30266825 | |
| 247 | Phosphorylation | SVASTPISQRRSQGR EEECCCHHHCHHCCC | 20.88 | 30266825 | |
| 251 | Phosphorylation | TPISQRRSQGRSCGP CCHHHCHHCCCCCCC | 38.89 | 25159151 | |
| 252 | Ubiquitination | PISQRRSQGRSCGPA CHHHCHHCCCCCCCC | 49.89 | 33845483 | |
| 255 | Phosphorylation | QRRSQGRSCGPASQS HCHHCCCCCCCCCHH | 30.19 | 23927012 | |
| 255 | Ubiquitination | QRRSQGRSCGPASQS HCHHCCCCCCCCCHH | 30.19 | 24816145 | |
| 260 | Phosphorylation | GRSCGPASQSTLGLK CCCCCCCCHHHHCCC | 28.00 | 21815630 | |
| 262 | Phosphorylation | SCGPASQSTLGLKGS CCCCCCHHHHCCCHH | 24.09 | 28152594 | |
| 263 | Phosphorylation | CGPASQSTLGLKGSL CCCCCHHHHCCCHHH | 19.74 | 28152594 | |
| 263 | Ubiquitination | CGPASQSTLGLKGSL CCCCCHHHHCCCHHH | 19.74 | 24816145 | |
| 264 | Ubiquitination | GPASQSTLGLKGSLK CCCCHHHHCCCHHHH | 10.28 | 24816145 | |
| 265 | Ubiquitination | PASQSTLGLKGSLKR CCCHHHHCCCHHHHH | 25.98 | 33845483 | |
| 266 | Ubiquitination | ASQSTLGLKGSLKRS CCHHHHCCCHHHHHH | 6.80 | 33845483 | |
| 267 | Methylation | SQSTLGLKGSLKRSA CHHHHCCCHHHHHHH | 44.66 | 115974421 | |
| 267 | Ubiquitination | SQSTLGLKGSLKRSA CHHHHCCCHHHHHHH | 44.66 | 33845483 | |
| 269 | Phosphorylation | STLGLKGSLKRSAIS HHHCCCHHHHHHHHH | 29.18 | 23401153 | |
| 270 | Ubiquitination | TLGLKGSLKRSAISA HHCCCHHHHHHHHHH | 7.92 | 24816145 | |
| 271 | Methylation | LGLKGSLKRSAISAA HCCCHHHHHHHHHHH | 46.10 | 115974425 | |
| 273 | Phosphorylation | LKGSLKRSAISAAKT CCHHHHHHHHHHHHH | 28.50 | 29396449 | |
| 276 | Phosphorylation | SLKRSAISAAKTGVR HHHHHHHHHHHHCCC | 23.14 | 33259812 | |
| 277 | Ubiquitination | LKRSAISAAKTGVRF HHHHHHHHHHHCCCE | 13.58 | 24816145 | |
| 278 | Ubiquitination | KRSAISAAKTGVRFS HHHHHHHHHHCCCEE | 11.80 | 24816145 | |
| 279 | Acetylation | RSAISAAKTGVRFSA HHHHHHHHHCCCEEE | 45.59 | 25953088 | |
| 279 | Ubiquitination | RSAISAAKTGVRFSA HHHHHHHHHCCCEEE | 45.59 | 24816145 | |
| 280 | Ubiquitination | SAISAAKTGVRFSAA HHHHHHHHCCCEEEC | 35.86 | 29967540 | |
| 284 | Ubiquitination | AAKTGVRFSAATKDN HHHHCCCEEECCCCC | 5.60 | 24816145 | |
| 285 | Phosphorylation | AKTGVRFSAATKDNE HHHCCCEEECCCCCH | 13.36 | 33259812 | |
| 285 | Ubiquitination | AKTGVRFSAATKDNE HHHCCCEEECCCCCH | 13.36 | 24816145 | |
| 289 | Acetylation | VRFSAATKDNEHKRS CCEEECCCCCHHHCC | 54.55 | 23749302 | |
| 289 | Ubiquitination | VRFSAATKDNEHKRS CCEEECCCCCHHHCC | 54.55 | 29967540 | |
| 292 | Ubiquitination | SAATKDNEHKRSLTK EECCCCCHHHCCCCC | 62.00 | 33845483 | |
| 293 | Ubiquitination | AATKDNEHKRSLTKT ECCCCCHHHCCCCCC | 36.76 | 24816145 | |
| 294 | Ubiquitination | ATKDNEHKRSLTKTP CCCCCHHHCCCCCCC | 37.19 | 24816145 | |
| 296 | Phosphorylation | KDNEHKRSLTKTPAR CCCHHHCCCCCCCCC | 45.23 | 25849741 | |
| 298 | Phosphorylation | NEHKRSLTKTPARKS CHHHCCCCCCCCCCC | 33.83 | 33259812 | |
| 299 | Acetylation | EHKRSLTKTPARKSA HHHCCCCCCCCCCCC | 58.78 | 25953088 | |
| 299 | Phosphorylation | EHKRSLTKTPARKSA HHHCCCCCCCCCCCC | 58.78 | 33259812 | |
| 299 | Ubiquitination | EHKRSLTKTPARKSA HHHCCCCCCCCCCCC | 58.78 | 24816145 | |
| 300 | Phosphorylation | HKRSLTKTPARKSAH HHCCCCCCCCCCCCE | 19.56 | 25849741 | |
| 300 | Ubiquitination | HKRSLTKTPARKSAH HHCCCCCCCCCCCCE | 19.56 | 24816145 | |
| 301 | Ubiquitination | KRSLTKTPARKSAHV HCCCCCCCCCCCCEE | 31.46 | 33845483 | |
| 302 | Ubiquitination | RSLTKTPARKSAHVT CCCCCCCCCCCCEEE | 36.44 | 29967540 | |
| 303 | Ubiquitination | SLTKTPARKSAHVTV CCCCCCCCCCCEEEE | 34.36 | 29967540 | |
| 304 | Ubiquitination | LTKTPARKSAHVTVS CCCCCCCCCCEEEEE | 54.85 | 29967540 | |
| 305 | O-linked_Glycosylation | TKTPARKSAHVTVSG CCCCCCCCCEEEEEC | 20.32 | 31373491 | |
| 305 | Phosphorylation | TKTPARKSAHVTVSG CCCCCCCCCEEEEEC | 20.32 | 25159151 | |
| 307 | Ubiquitination | TPARKSAHVTVSGGT CCCCCCCEEEEECCC | 23.91 | 16196087 | |
| 309 | Phosphorylation | ARKSAHVTVSGGTPK CCCCCEEEEECCCCC | 10.09 | 23927012 | |
| 310 | Ubiquitination | RKSAHVTVSGGTPKG CCCCEEEEECCCCCC | 4.94 | 33845483 | |
| 311 | Phosphorylation | KSAHVTVSGGTPKGE CCCEEEEECCCCCCE | 23.34 | 23927012 | |
| 312 | Ubiquitination | SAHVTVSGGTPKGEA CCEEEEECCCCCCEE | 39.39 | 33845483 | |
| 314 | Phosphorylation | HVTVSGGTPKGEAVL EEEEECCCCCCEEEE | 25.92 | 20201521 | |
| 314 | Ubiquitination | HVTVSGGTPKGEAVL EEEEECCCCCCEEEE | 25.92 | 33845483 | |
| 315 | Ubiquitination | VTVSGGTPKGEAVLG EEEECCCCCCEEEEE | 46.02 | 33845483 | |
| 316 | Ubiquitination | TVSGGTPKGEAVLGT EEECCCCCCEEEEEE | 70.04 | 33845483 | |
| 321 | Ubiquitination | TPKGEAVLGTHKLKT CCCCEEEEEEEEEEE | 9.38 | 16196087 | |
| 322 | Ubiquitination | PKGEAVLGTHKLKTI CCCEEEEEEEEEEEE | 21.12 | 16196087 | |
| 323 | Phosphorylation | KGEAVLGTHKLKTIT CCEEEEEEEEEEEEC | 16.21 | 30576142 | |
| 323 | Ubiquitination | KGEAVLGTHKLKTIT CCEEEEEEEEEEEEC | 16.21 | 33845483 | |
| 324 | Ubiquitination | GEAVLGTHKLKTITG CEEEEEEEEEEEECC | 31.49 | 33845483 | |
| 325 | Ubiquitination | EAVLGTHKLKTITGN EEEEEEEEEEEECCC | 52.06 | 33845483 | |
| 326 | Ubiquitination | AVLGTHKLKTITGNS EEEEEEEEEEECCCC | 4.61 | 33845483 | |
| 327 | Ubiquitination | VLGTHKLKTITGNSA EEEEEEEEEECCCCC | 42.56 | 33845483 | |
| 333 | Phosphorylation | LKTITGNSAAVITPF EEEECCCCCEEEECE | 20.96 | 19664995 | |
| 338 | Phosphorylation | GNSAAVITPFKLTTE CCCCEEEECEEEECC | 18.97 | 25159151 | |
| 339 | Ubiquitination | NSAAVITPFKLTTEA CCCEEEECEEEECCC | 17.16 | 33845483 | |
| 340 | Ubiquitination | SAAVITPFKLTTEAT CCEEEECEEEECCCC | 8.30 | 33845483 | |
| 341 | Ubiquitination | AAVITPFKLTTEATQ CEEEECEEEECCCCC | 46.24 | 29967540 | |
| 343 | Phosphorylation | VITPFKLTTEATQTP EEECEEEECCCCCCC | 24.15 | 18669648 | |
| 344 | Phosphorylation | ITPFKLTTEATQTPV EECEEEECCCCCCCC | 33.78 | 30266825 | |
| 346 | Ubiquitination | PFKLTTEATQTPVSN CEEEECCCCCCCCCC | 11.69 | 29967540 | |
| 347 | Phosphorylation | FKLTTEATQTPVSNK EEEECCCCCCCCCCC | 27.09 | 30266825 | |
| 348 | Acetylation | KLTTEATQTPVSNKK EEECCCCCCCCCCCC | 51.35 | 19608861 | |
| 349 | Phosphorylation | LTTEATQTPVSNKKP EECCCCCCCCCCCCC | 22.69 | 23401153 | |
| 352 | Phosphorylation | EATQTPVSNKKPVFD CCCCCCCCCCCCEEE | 44.10 | 23401153 | |
| 352 | Ubiquitination | EATQTPVSNKKPVFD CCCCCCCCCCCCEEE | 44.10 | 33845483 | |
| 353 | Ubiquitination | ATQTPVSNKKPVFDL CCCCCCCCCCCEEEC | 57.51 | 33845483 | |
| 354 | Acetylation | TQTPVSNKKPVFDLK CCCCCCCCCCEEECC | 51.45 | 25953088 | |
| 354 | Ubiquitination | TQTPVSNKKPVFDLK CCCCCCCCCCEEECC | 51.45 | 33845483 | |
| 355 | Ubiquitination | QTPVSNKKPVFDLKA CCCCCCCCCEEECCH | 51.14 | 33845483 | |
| 359 | Ubiquitination | SNKKPVFDLKASLSR CCCCCEEECCHHHCC | 47.71 | 29967540 | |
| 360 | Ubiquitination | NKKPVFDLKASLSRP CCCCEEECCHHHCCC | 3.20 | 29967540 | |
| 361 | Ubiquitination | KKPVFDLKASLSRPL CCCEEECCHHHCCCC | 37.46 | 29967540 | |
| 363 | Phosphorylation | PVFDLKASLSRPLNY CEEECCHHHCCCCCC | 25.87 | 25159151 | |
| 363 | Ubiquitination | PVFDLKASLSRPLNY CEEECCHHHCCCCCC | 25.87 | 29967540 | |
| 365 | Phosphorylation | FDLKASLSRPLNYEP EECCHHHCCCCCCCC | 29.38 | 20068231 | |
| 365 | Ubiquitination | FDLKASLSRPLNYEP EECCHHHCCCCCCCC | 29.38 | 24816145 | |
| 369 | Ubiquitination | ASLSRPLNYEPHKGK HHHCCCCCCCCCCCC | 41.63 | 29967540 | |
| 370 | Phosphorylation | SLSRPLNYEPHKGKL HHCCCCCCCCCCCCC | 38.22 | 27080861 | |
| 373 | Ubiquitination | RPLNYEPHKGKLKPW CCCCCCCCCCCCCCC | 39.29 | 24816145 | |
| 374 | Ubiquitination | PLNYEPHKGKLKPWG CCCCCCCCCCCCCCC | 69.34 | 29967540 | |
| 375 | Ubiquitination | LNYEPHKGKLKPWGQ CCCCCCCCCCCCCCC | 37.18 | 29967540 | |
| 376 | Acetylation | NYEPHKGKLKPWGQS CCCCCCCCCCCCCCC | 59.13 | 25953088 | |
| 376 | Ubiquitination | NYEPHKGKLKPWGQS CCCCCCCCCCCCCCC | 59.13 | 29967540 | |
| 377 | Ubiquitination | YEPHKGKLKPWGQSK CCCCCCCCCCCCCCC | 12.57 | 29967540 | |
| 378 | Ubiquitination | EPHKGKLKPWGQSKE CCCCCCCCCCCCCCC | 42.06 | 29967540 | |
| 382 | Ubiquitination | GKLKPWGQSKENNYL CCCCCCCCCCCCCHH | 47.68 | 29967540 | |
| 383 | Ubiquitination | KLKPWGQSKENNYLN CCCCCCCCCCCCHHH | 37.69 | 29967540 | |
| 384 | Methylation | LKPWGQSKENNYLNQ CCCCCCCCCCCHHHH | 57.48 | 115974429 | |
| 384 | Ubiquitination | LKPWGQSKENNYLNQ CCCCCCCCCCCHHHH | 57.48 | 29967540 | |
| 388 | Phosphorylation | GQSKENNYLNQHVNR CCCCCCCHHHHHHHH | 20.72 | 27642862 | |
| 388 | Ubiquitination | GQSKENNYLNQHVNR CCCCCCCHHHHHHHH | 20.72 | 24816145 | |
| 389 | Ubiquitination | QSKENNYLNQHVNRI CCCCCCHHHHHHHHH | 5.59 | 29967540 | |
| 394 | Ubiquitination | NYLNQHVNRINFYKK CHHHHHHHHHHHHHH | 36.67 | 24816145 | |
| 395 | Ubiquitination | YLNQHVNRINFYKKT HHHHHHHHHHHHHHH | 24.92 | 24816145 | |
| 396 | Acetylation | LNQHVNRINFYKKTY HHHHHHHHHHHHHHH | 3.36 | 19608861 | |
| 402 | Ubiquitination | RINFYKKTYKQPHLQ HHHHHHHHHCCCCCC | 31.62 | 29967540 | |
| 403 | Ubiquitination | INFYKKTYKQPHLQT HHHHHHHHCCCCCCC | 19.26 | 29967540 | |
| 404 | Acetylation | NFYKKTYKQPHLQTK HHHHHHHCCCCCCCH | 63.69 | 25953088 | |
| 404 | Ubiquitination | NFYKKTYKQPHLQTK HHHHHHHCCCCCCCH | 63.69 | 29967540 | |
| 409 | Acetylation | TYKQPHLQTKEEQRK HHCCCCCCCHHHHHH | 47.71 | 19608861 | |
| 410 | Acetylation | YKQPHLQTKEEQRKK HCCCCCCCHHHHHHH | 46.94 | 19608861 | |
| 411 | Acetylation | KQPHLQTKEEQRKKR CCCCCCCHHHHHHHH | 46.42 | 19608861 | |
| 412 | Ubiquitination | QPHLQTKEEQRKKRE CCCCCCHHHHHHHHH | 63.85 | 24816145 | |
| 413 | Ubiquitination | PHLQTKEEQRKKREQ CCCCCHHHHHHHHHH | 58.19 | 24816145 | |
| 419 | Ubiquitination | EEQRKKREQERKEKK HHHHHHHHHHHHHHH | 66.72 | 24816145 | |
| 426 | Ubiquitination | EQERKEKKAKVLGMR HHHHHHHHHHHHHHH | 55.31 | 24816145 | |
| 427 | Ubiquitination | QERKEKKAKVLGMRR HHHHHHHHHHHHHHC | 20.46 | 24816145 | |
| 428 | Ubiquitination | ERKEKKAKVLGMRRG HHHHHHHHHHHHHCC | 47.04 | 24816145 | |
| 433 | Ubiquitination | KAKVLGMRRGLILAE HHHHHHHHCCEEEEC | 27.93 | 24816145 | |
| 434 | Ubiquitination | AKVLGMRRGLILAED HHHHHHHCCEEEECC | 35.06 | 24816145 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 124 | S | Phosphorylation | Kinase | ATM | Q13315 | Uniprot |
| 240 | S | Phosphorylation | Kinase | AURKA | O14965 | GPS |
| 240 | S | Phosphorylation | Kinase | AURKB | Q96GD4 | GPS |
| 300 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 338 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | FZR1 | Q9UM11 | PMID:17618083 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NUSAP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NUSAP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| UBE4B_HUMAN | UBE4B | physical | 22863883 | |
| CEP70_HUMAN | CEP70 | physical | 25416956 | |
| IMB1_HUMAN | KPNB1 | physical | 26186194 | |
| IPO7_HUMAN | IPO7 | physical | 26186194 | |
| G3PT_HUMAN | GAPDHS | physical | 26186194 | |
| RBP2_HUMAN | RANBP2 | physical | 26186194 | |
| CYTM_HUMAN | CST6 | physical | 26186194 | |
| NU153_HUMAN | NUP153 | physical | 26186194 | |
| S100P_HUMAN | S100P | physical | 26186194 | |
| CE030_HUMAN | C5orf30 | physical | 26186194 | |
| GSTA2_HUMAN | GSTA2 | physical | 26186194 | |
| CAF1A_HUMAN | CHAF1A | physical | 26344197 | |
| CE030_HUMAN | C5orf30 | physical | 28514442 | |
| S100P_HUMAN | S100P | physical | 28514442 | |
| G3PT_HUMAN | GAPDHS | physical | 28514442 | |
| GSTA2_HUMAN | GSTA2 | physical | 28514442 | |
| RBP2_HUMAN | RANBP2 | physical | 28514442 | |
| CYTM_HUMAN | CST6 | physical | 28514442 | |
| NU153_HUMAN | NUP153 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-411, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-349 AND SER-352, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-135; THR-182; SER-240;THR-244; SER-247; THR-314; THR-349 AND SER-352, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240; THR-244 ANDSER-247, AND MASS SPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-135, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124, AND MASSSPECTROMETRY. | |
| "Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-135, AND MASSSPECTROMETRY. | |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-338, AND MASSSPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-314, AND MASSSPECTROMETRY. | |